ORIC Pharmaceuticals, Inc.

NASDAQ:ORIC

Biotechnology

Healthcare
$7.70 -0.75%

-$0.07 today

Market cap
$800.27M
Beta
1.06
P/E (TTM)
-6.7
EPS (TTM)
-$1.28
52W Low $7.23High $14.93

Volume 1.07M

Average 1.91M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$113.37M

FY 2025 · Annual

Investing Cash Flow

-$148.03M

FY 2025 · Annual

Financing Cash Flow

$247.66M

FY 2025 · Annual

+95.7% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(78.72M)(89.12M)(100.7M)(127.85M)(129.47M)
Depreciation & Amortization897K966K1.03M1.11M1.22M
Deferred Income Tax00000
Stock-Based Compensation12.85M14.46M15.23M20.21M0
Change in Working Capital4.07M(445K)4.9M1.97M(5.46M)
Accounts Receivables00000
Inventory00000
Accounts Payables2.93M(1.48M)01.83M(7.25M)
Other Working Capital1.14M1.03M4.9M143K1.79M
Other Non-Cash Items1.35M(1M)(6.15M)(8.1M)20.34M
Operating Cash Flow(59.54M)(75.14M)(85.69M)(112.66M)(113.37M)
Capital Expenditures(939K)(2.08M)(849K)(1.19M)(712K)
Acquisitions (Net)1.38M2.08M000
Purchases of Investments(69.63M)(238.12M)(239.24M)(251.92M)(399.82M)
Sales of Investments229M130.95M196.69M275.25M252.5M
Other Investing Activities(1.38M)(2.08M)000
Investing Cash Flow158.44M(109.25M)(43.4M)22.14M(148.03M)
Debt Repayment00000
Common Stock Issued50M25M85M125M247.66M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(866K)225K658K1.55M0
Financing Cash Flow49.13M25.23M85.66M126.55M247.66M
Effect of Forex Changes00000
Net Change in Cash148.03M(159.17M)(43.43M)36.02M(13.74M)
Free Cash Flow(60.48M)(77.22M)(86.54M)(113.85M)(114.08M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$129.5M
+ D&A$1.2M
+ Stock-Based Comp$0
+ Deferred Tax$0
- Working Capital-$5.5M
+ Other Non-Cash$20.3M
= Operating Cash Flow-$113.4M
- Capex-$712.0K
= Free Cash Flow-$114.1M

Analysis

FY2025 free cash flow is -$114.1M. FCF conversion is 88.1% of net income. Operating cash flow was -$113.4M, with capex of -$712.0K. The largest bridge item is Other Non-Cash at $20.3M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportOct 23, 2026
4Statement of changes in beneficial ownershipOct 21, 2026
4Statement of changes in beneficial ownershipOct 2, 2026
4Statement of changes in beneficial ownershipSep 29, 2026
4Statement of changes in beneficial ownershipSep 25, 2026

Does ORIC generate free cash flow?

ORIC Pharmaceuticals, Inc. (ORIC) generated -$114.08M of free cash flow in fiscal 2025.

How much operating cash flow does ORIC produce?

Operating cash flow was -$113.37M, before capital expenditures of $712,000.00.